Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Yttrium-90 × Clear all

NCT05620771 2026-05-26

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular